{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:42:01Z","timestamp":1786372921495,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.2215\/cjn.00140110","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T21:00:02Z","timestamp":1268946002000},"page":"964-971","source":"Crossref","is-referenced-by-count":8,"title":["Nephrogenic Systemic Fibrosis"],"prefix":"10.2215","volume":"5","author":[{"given":"Khaled","family":"Abdel-Kader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priti R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Kallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronda L.","family":"Sinkowitz-Cochran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren K.","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Unruh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20230601","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxoedema-like cutaneous diseases in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"key":"R2-4-20230601","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2005.08.008","article-title":"Nephrogenic systemic fibrosis: The nosological and conceptual evolution of nephrogenic fibrosing dermopathy","volume":"46","author":"Cowper","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R3-4-20230601","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00000372-200308000-00017","article-title":"Nephrogenic fibrosing dermopathy: Suspect identified, motive unclear","volume":"25","author":"Cowper","year":"2003","journal-title":"Am J Dermatopathol"},{"key":"R4-4-20230601","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.139.7.903","article-title":"Nephrogenic fibrosing dermopathy with systemic involvement","volume":"139","author":"Ting","year":"2003","journal-title":"Arch Dermatol"},{"key":"R5-4-20230601","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5858\/2006-130-209-MIINFD","article-title":"Multiorgan involvement in nephrogenic fibrosing dermopathy: An autopsy case and review of the literature","volume":"130","author":"Gibson","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"R6-4-20230601","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/archderm.139.7.928","article-title":"What nephrogenic fibrosing dermopathy might be","volume":"139","author":"LeBoit","year":"2003","journal-title":"Arch Dermatol"},{"key":"R7-4-20230601","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.ajkd.2005.06.024","article-title":"Nephrogenic fibrosing dermopathy\/nephrogenic systemic fibrosis: Report of a new case with literature review","volume":"46","author":"Daram","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R8-4-20230601","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium\u2014A specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R9-4-20230601","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1681\/ASN.2006060601","article-title":"Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging","volume":"17","author":"Marckmann","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R11-4-20230601","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1148\/radiol.2451070353","article-title":"Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: Retrospective study of a renal replacement therapy cohort","volume":"245","author":"Collidge","year":"2007","journal-title":"Radiology"},{"key":"R12-4-20230601","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2215\/CJN.03921106","article-title":"Nephrogenic systemic fibrosis: A population study examining the relationship of disease development to gadolinium exposure","volume":"2","author":"Deo","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R13-4-20230601","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1093\/ndt\/gfm584","article-title":"Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure","volume":"22","author":"Othersen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R14-4-20230601","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.22925","article-title":"Cutaneous changes of nephrogenic systemic fibrosis: Predictor of early mortality and association with gadolinium exposure","volume":"56","author":"Todd","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R15-4-20230601","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.ajkd.2007.12.036","article-title":"Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: A case-control study","volume":"51","author":"Kallen","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R16-4-20230601","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/ndt\/gfn593","article-title":"Gadolinium-based contrast agents and nephrogenic systemic fibrosis: A systematic review and meta-analysis","volume":"24","author":"Agarwal","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R18-4-20230601","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MNH.0b013e3283309660","article-title":"Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: The perfect storm","volume":"18","author":"Perazella","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R19-4-20230601","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2215\/CJN.06011108","article-title":"Current status of gadolinium toxicity in patients with kidney disease","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-4-20230601","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.jacc.2008.12.061","article-title":"Nephrogenic systemic fibrosis: Pathogenesis, diagnosis, and therapy","volume":"53","author":"Kribben","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R21-4-20230601","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mric.2009.01.003","article-title":"Nephrogenic systemic fibrosis","volume":"17","author":"Weinreb","year":"2009","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"R22-4-20230601","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2215\/CJN.03250906","article-title":"Nephrogenic systemic fibrosis: A mysterious disease in patients with renal failure\u2014Role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate","volume":"2","author":"Yerram","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-4-20230601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02841850903209218","article-title":"Nephrogenic systemic fibrosis and contrast medium-induced nephropathy: A choice between the devil and the deep blue sea for patients with reduced renal function?","volume":"50","author":"Lind-Ramskov","year":"2009","journal-title":"Acta Radiol"},{"key":"R24-4-20230601","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2502080498","article-title":"Nephrogenic systemic fibrosis: Incidence, associations, and effect of risk factor assessment\u2014Report of 33 cases","volume":"250","author":"Perez-Rodriguez","year":"2009","journal-title":"Radiology"},{"key":"R25-4-20230601","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1148\/rg.291085072","article-title":"MR imaging in patients at risk for developing nephrogenic systemic fibrosis: Protocols, practices, and imaging techniques to maximize patient safety","volume":"29","author":"Juluru","year":"2009","journal-title":"Radiographics"},{"key":"R26-4-20230601","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jacr.2007.08.012","article-title":"Impact on hospital policy: Yale experience","volume":"5","author":"Weinreb","year":"2008","journal-title":"J Am Coll Radiol"},{"key":"R28-4-20230601","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejrad.2008.01.029","article-title":"Nephrogenic system fibrosis: A radiologist's practical perspective","volume":"66","author":"Martin","year":"2008","journal-title":"Eur J Radiol"},{"key":"R29-4-20230601","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jmri.21368","article-title":"Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: The role of excess ligand","volume":"27","author":"Sieber","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"R30-4-20230601","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1007\/s00330-008-0977-y","article-title":"Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions","volume":"18","author":"Sieber","year":"2008","journal-title":"Eur Radiol"},{"key":"R31-4-20230601","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejrad.2008.02.011","article-title":"Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting","volume":"66","author":"Broome","year":"2008","journal-title":"Eur J Radiol"},{"key":"R32-4-20230601","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2215\/CJN.05721207","article-title":"Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis","volume":"3","author":"Reilly","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R36-4-20230601","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacr.2007.08.014","article-title":"Gadolinium-containing MRI contrast agents: Important variations on a theme for NSF","volume":"5","author":"Kuo","year":"2008","journal-title":"J Am Coll Radiol"},{"key":"R37-4-20230601","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1148\/radiol.2483072093","article-title":"Risk of nephrogenic systemic fibrosis: Evaluation of gadolinium chelate contrast agents at four American universities","volume":"248","author":"Wertman","year":"2008","journal-title":"Radiology"},{"key":"R38-4-20230601","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejrad.2008.01.028","article-title":"Nephrogenic systemic fibrosis\u2014Implications for nephrologists","volume":"66","author":"Saab","year":"2008","journal-title":"Eur J Radiol"},{"key":"R39-4-20230601","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1148\/radiol.2431062144","article-title":"Nephrogenic systemic fibrosis: Risk factors and incidence estimation","volume":"243","author":"Sadowski","year":"2007","journal-title":"Radiology"},{"key":"R40-4-20230601","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"R41-4-20230601","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.ki.5002343","article-title":"Chronic kidney disease as a global public health problem: Approaches and initiatives\u2014A position statement from Kidney Disease Improving Global Outcomes","volume":"72","author":"Levey","year":"2007","journal-title":"Kidney Int"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201006000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:32Z","timestamp":1786369172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201006000-00004"}},"subtitle":["A Survey of Nephrologists' Perceptions and Practices"],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.00140110","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}